Probiotic-Fermented Milk Produces Peptides With Antidiabetic and Antimicrobial Effects

Fermenting milk with a two-strain probiotic consortium (Bacillus spizizenii and Bacillus subtilis) produced bioactive peptides with markedly enhanced multi-functional activity compared to single-strain fermentation. The consortium peptides achieved 90.80% α-amylase inhibition (relevant to diabetes management), 54.17% ABTS radical scavenging (antioxidant activity), and potent antimicrobial activity with MICs of 2.5–5 µg/mL against five bacterial pathogens including Pseudomonas aeruginosa and Staphylococcus aureus.

Milk was fermented using either single Bacillus strains or a two-strain consortium. Bioactive peptides (≤10 kDa) were purified from the fermented milk and characterized using reverse-phase HPLC and high-resolution LC-MS/MS. The peptides were then tested for α-amylase inhibition (a marker of antidiabetic potential), ABTS radical scavenging (antioxidant capacity), and antimicrobial activity via minimum inhibitory concentration (MIC) testing against five bacterial species.

Most research on milk-derived bioactive peptides uses single probiotic strains. This study shows that combining two indigenous probiotic strains produces peptides with stronger antidiabetic, antioxidant, and antimicrobial properties than either strain alone — suggesting that multi-strain fermentation could unlock more potent functional foods.

Food-derived bioactive peptides are a growing area of functional food research. This study adds to the evidence that fermentation conditions — particularly which microbes you use — dramatically affect the bioactivity of the peptides produced. Multi-strain consortia could become a standard approach for producing more potent functional dairy products.

This was entirely an in vitro (lab-based) study — no animal or human testing was conducted. The bioactive peptides were not individually isolated and characterized, so it's unclear which specific peptides are responsible for the observed activities. Bioavailability, digestive stability, and in vivo efficacy remain unknown. The study used specific indigenous Bacillus strains that may not be commercially available.